Schisandrin C enhances cGAS-STING pathway activation and inhibits HBV replication

• Published in: Journal of ethnopharmacology 2023-07, Vol.311, p.116427, Article 116427
• Main Authors: Zhao, Jia, Xu, Guang, Hou, Xiaorong, Mu, Wenqing, Yang, Huijie, Shi, Wei, Wen, Jincai, Liu, Tingting, Wu, Zhixin, Bai, Jun, Zhang, Ping, Wang, Zhongxia, Xiao, Xiaohe, Zou, Wenjun, Bai, Zhaofang, Zhan, Xiaoyan
• Format: Article
• Language: English
• Subjects: Animals; cGAS-STING pathway; HBV; Hepatitis B virus - genetics; IFN β; Immunity, Innate; Interferon-beta - metabolism; Mice; Nucleotidyltransferases - metabolism; Schisandra chinensis; Schisandrin C; Signal Transduction; TBK1
• ISSN: 0378-8741; 1872-7573; 1872-7573
• DOI: 10.1016/j.jep.2023.116427

Schisandra Chinensis (Turcz.) Baill. is a long-term used traditional Chinese medicine with the functions of tonifying the kidney and calming the heart, tonifying qi and engendering fluid. It can be used to treat insomnia and dreaminess, spermatorrhea, coughs, as well as liver and kidney deficiency of Yin or Yang Syndrome. Modern pharmacological studies have shown that Schisandra Chinensis regulates host immunity and exhibits anti-cancer, antiviral and liver-protecting effects. However, the specific mechanism by which Schisandra Chinensis modulates antiviral immunity is unknown. We sought to explore the therapeutic effect of the active components of Schisandra Chinensis on anti-viral immunity and further investigate the underlying mechanism. Immunoblotting, quantitative real-time PCR, enzyme-linked immunosorbent assay, immunofluorescence, and immunoprecipitation were used to investigate the effect of schisandrin C (SC), one of the most abundant and biologically active components of Schisandra Chinensis, on the activation of cGAS-STING signaling pathway and the underlying mechanism. In addition, CMA-mediated STING activation and hydrodynamic injection-mediated HBV-replicating mouse model were used to investigate the effect of SC on the activation of STING signaling pathway and its antiviral effect in vivo. SC promoted cGAS-STING pathway activation, accompanied by increased production of interferon β (IFN β) and downstream gene expression. Moreover, SC also exerted anti-HBV effects, reducing HBeAg, HBcAg, HBsAg, and HBV DNA levels in hydrodynamic injection-mediated HBV-replicating mouse model and elevating the production of IFN β and expression of interferon-stimulated genes (IFIT1, ISG15, and CXCL10). Mechanistically, SC could facilitate the interaction between TANK-binding kinase 1 (TBK1) and STING, which is important for IRF3 phosphorylation and production of IFN β. Our study confirmed that SC enhances cGAS-STING pathway activation and inhibits HBV replication, as well as provides clues for chronic hepatitis B and other infectious diseases treated by SC. [Display omitted] •Schisandrin C (SC) promotes cGAS-STING pathway activation.•SC promotes cGAS-STING pathway activation by facilitating the interaction between TBK1 and STING.•SC markedly attenuates hepatitis B virus replication in vivo and promotes the expression of IFN β and ISGs.